Genprex, Inc. 8-K Filing: Real-Time SEC Disclosure on GNPX Stock

Here are the key insights extracted from the provided section of the financial report:
- Entity Information:
- Company Name: Genprex, Inc.
- State of Incorporation: Delaware (DE)
- CIK Number: 0001595248
- SEC File Number: 001-38244
- EIN: 90-0772347
- Address: 3300 Bee Cave Road, #650-227, Austin, TX 78746
- Phone Number: 512-537-7997
- Filing Details:
- Filing Type: 8-K
- Filing Date: February 17, 2025
- Stock Information:
- Common Stock Symbol: GNPX
- Exchange: NASDAQ
- Period of Reporting:
- Reporting Period Start Date: February 17, 2025
- Reporting Period End Date: February 17, 2025
- XBRL Information:
- XBRL Version: 1.0
- Schema Reference: gnpx-20250217.xsd
This report indicates that Genprex, Inc. is making a filing with the SEC, specifically an 8-K, which typically reports unscheduled material events or corporate changes. The filing date and reporting period are the same, suggesting that this may be a real-time disclosure. The company is publicly traded on NASDAQ under the symbol GNPX.